Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 10, 1999, Pages 755-762

  Si, Xiaochen ^a   Webb, R Clinton ^a   Richey, Joyce M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Aortae; Free fatty acids; Hypertriglyceridemia; Sprague Dawley rats; Vascular reactivity

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ANTILIPEMIC AGENT; BEZAFIBRATE; FATTY ACID; FRUCTOSE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUGAR INTAKE;

EID: 0033403956     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-061     Document Type: Article

References (41)

1. Abe, H., Tamada, N., Kamata, K., Kuwaki, T., Shimada, M., Osuga, J., Shionoiri, F., Yahagi, N., Kadowaki, T., Tamemoto, H., Ishibashi, S., Yazaki, Y., and Makuuchi, M. 1998. Hypertension, hypertriglyceridemia and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest. 101: 1784-1788.
2. Agrawal, B., Kopecky, J., Krazlin, B., Rohmeiss, P., Pill, J., and Gretz, N. 1998. Acute effects of bezafibrate on blood pressure and renal hemodynamics in SHR and WKY rats. Nephrol. Dial. Transplant, 13: 333-339.
3. Banos, G., Carvajal, K., Cardoso, G., Zamora, J., and Franco, M. 1997. Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension. Am. J. Hypertens. 10: 379-388.
4. Berne, C., Fagius, J., Pollare, T., and Hjemdahl, P. 1992. The sympathetic response to euglycaemic hyperinsulinemia. Diabetologia, 35: 873-879.
5. Blaustein, M.P. 1977. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 232: 165-173.
6. Bohr, D.F., and Webb, R.C. 1988. Vascular smooth muscle membrane in hypertension. Annu. Rev. Pharmacol. Toxicol. 28: 389-409.
7. Brands, M.W., Garrity, C.A., Holmann, B.B., Keen, H.L., Alonso-Galicia, M., and Hall, J.E. 1994. High-fructose diet does not raise 24-hours mean arterial pressure in rats. Am. J. Hypertens. 7: 104-109.
8. Bruner, C.A., and Webb, R.C. 1990. Increased vascular reactivity to Bay K 8644 in genetic hypertension. Pharmacology, 41: 24-35.
9. Chen, M., Preston-Mason, R., and Tulenko, T.N. 1995. Athersclerosis alters the composition, structure and function of arterial smooth muscle cell plasma membranes. Biochim. Biophys. Acta, 1272: 101-112.
10. Dai, S., and McNeill, J.H. 1992. Effects of fructose loading in streptozotocin-diabetic and nondiabetic rats. Can. J. Physiol. Pharmacol. 70: 1583-1589.
11. Dominiczak, A.F., Webb, R.C., and Bohr, D.F. 1991. Calcium and the malfunction of the plasma membrane in hypertension. J. Vasc. Med. Biol. 3: 178-180.
12. Dubey, R.K., Kotchen, T.A., Boegehold, M.A., and Kotchen, T.A. 1992. Pioglitazone (PIO) attenuates hypertension and inhibits growth of arteriolar smooth muscle cells (ASMC). FASEB J. 6: A1251. (Abstr.)
13. Godfraind, T., Morel, N, and Wibo, M. 1990. Modulation of the action of calcium antagonists in arteries. Blood Vessels, 27: 184-196.
14. Herlihy, J.T., Johns, A., and Harper, M.J. 1987. Modulation of vascular smooth muscle sensitivity by preload and eicosanoid synthesis inhibition. Am. J. Physiol. 253: H1492-H1498.
15. Holness, M.J. 1994. Hypertriglyceridemia precedes impaired muscle glucose utilization during fructose feeding. Biochem. Soc. Trans. 22: 105S.
16. Hwang, I.-S., Ho, H., Hoffman, B.B., and Reaven, G.M. 1987. Fructose-induced insulin resistance and hypertension. Hypertension, 10: 512-516.
17. Iyer, S.N., and Katovich, M.J. 1996. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin. Exp. Hypertens. 18: 227-242.
18. Katakam, P.V., Ujhelyi, M.R., Hoenig, M.E., and Miller, A.W. 1998. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am. J. Physiol. 275: R788-R792.
19. Kazumi, T., Yoshino, G., Iwai, M., Matsuba, K., Matsushita, M., Iwatani, I., Kasama, T., Yoshida, M., and Baba, S. 1990. Long-term effects of bezafibrate on in vivo VLDL-triglyceride production in the rat. Diabetes Res. Clin. Practice, 9: 163-168.
20. Kunes, J., Bin-Talib, H.K., Dobesova, Z., Vrana, A., and Zicha, J. 1994. Erythrocyte ion transport alterations in hypertriglyceridemic rats. Clin. Sci. 86: 11-13.
21. Landsberg, L. 1986. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q. J. Med. 236: 1081-1090.
22. Liang, C.S., Doherty, J.U., Faillace, R., Maekawa, K., Arnold, S., Gavras, H., and Hood, W.B., Jr. 1982. Insulin infusion in conscious dogs: effects on systemic and coronary hemodynamics, regional blood flows and plasma catecholamines. J. Clin. Invest. 69: 1321-1336.
23. Matsui, H., Okumura, K., Kawakami, K., Hibino, M., Toki, Y., and Ito, T. 1997. Improved insulin sensitivity by bezafibrate in rats. Relationship to fatty acid composition of skeletal-muscle triglycerides. Diabetes, 46: 348-359.
24. Muzulu, S.I., Bing, R.F., and Norman, R.I. 1995. Human erythrocyte membrane fluidity and calcium pump activity in primary combined hyperlipidemia. Clin. Sci. 88: 307-310.
25. Ock-Jin, P., Denise, C., Dennis, F., et al. 1992. Mechanisms of fructose-induced hypertriglyceridemia in the rat: activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase. Biochem. J. 282: 753-757.
26. 2+ binding and membrane fluidity in essential and renal hypertension. Clin. Sci. 63: 281-284.
27. Pagnan, A., Corrocher, R., Ambrosio, G.B., Ferrari, S., Guarini, P., Piccolo, D., Opportuno, A., Bassi, A., Olivieri, O., and Baggio, G. 1989. Effects of an olive-rich diet on erythrocyte membrane lipid composition and cation transport system. Clin. Sci. 76: 87-93.
28. Porsa, E., Harper, M.J., and Herlihy J.T. 1989. Effects of preload and eicosanoid synthesis inhibition on rat aortic smooth muscle sensitivity. Prostaglandins Leukot. Essent. Fatty Acids, 38: 61-65.
29. Reaven, G.M. 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-1607.
30. Reaven, G.M., Ho, H., and Hoffman, B.B. 1988. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension, 12: 129-132.
31. Reaven, G.M., Ho, H., and Hoffman, B.B. 1989. Somatostatin inhibition of fructose-induced hypertension. Hypertension, 14: 117-120.
32. Richey, J.M., Si, X, Halter J.B., and Webb, R.C. 1998. Fructose perfusion in rat mesenteric arteries impairs endothelium-dependent vasodilation. Life Sci. 62: PL55-PL62.
33. Sang, K.M.L.Q., Mazeaud, M., Astarie, C., Duranthon, V., Driss, F., and Devynck, M.A. 1993. Plasma lipids and platelet membrane fluidity in essential hypertension. Thromb. Haemostasis, 69:70-76.
34. Sawicki, P.T., Heinemann, L., Starke, A., and Berger, M. 1992. Hyperinsulinemia is not linked with blood pressure elevations in patients with insulinomas. Diabetologia, 35: 649-658.
35. Shand, J.H., and West, D.W. 1994. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rats. Lipids, 29: 747-752.
36. Shepherd, J., Packard, C.J., Stewart, J.M., Atmeh, R.F., Clark, R.S., Boag, D.E., Carr, K., Lorimer, A.R., Ballantyne, D., and Morgan, H.G. 1984. Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects. J. Clin. Invest. 74: 2164-2177.
37. Trzeciak, H.I., Okopien, B., Kozlowski, A., Chocilowska, D., and Bara, A. 1993. Contractility of the tail artery in rats treated with bezafibrate and fed atherogenic diet. J. Cardiovasc. Pharmacol. 22: 761-767.
38. Verma, S., Bhanot, S., Yao, L., and McNeill, J.H. 1996. Defective endothelium-dependent relaxation in fructose-hypertensive rats. Am. J. Hypertens. 9: 370-376.
39. Verma, S., Skarsgard, P., Bhanot, S., Yao, L., Laher, I., and McNeill, J.H. 1997. Reactivity of mesenteric arteries from fructose hypertensive rats to endothelin-1. Am.J. Hypertens. 10: 1010-1019.
40. Vessby,B., Lithell,H., and Ledermann,H. 1982. Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate. Atherosclerosis, 44: 113-118.
41. Yoshino, G., Iwai, M., Tsutomu, K., Matsushita, M., Morita, M., Matsuba, K., Iwatani, I., and Baba, S. 1989. Effects of dietary fructose on triglyceride turnover in streptozotocin-diabetic rats. Atherosclerosis, 79: 41-46.